All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @dt.roth on TikTok · 62s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @dt.roth's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00So what side effects am I going to get from taking peptides?
  2. 0:02Peptides are amino acid profiles within the body
  3. 0:06that your body creates already.
  4. 0:07We create IGF, we create BPC,
  5. 0:10we create these aminos in the body.
  6. 0:13So how can you get a side effect
  7. 0:16from things that your body creates?
  8. 0:18Well, anything of too much is bad for you, right?
  9. 0:21But if you're taking BPC, what's the side effect?
  10. 0:23Recovery, reduce inflammation, got health increase.
  11. 0:27There's no really side effect to that.
  12. 0:29And you're going to be in 500.
  13. 0:30Increase your tendon repair,
  14. 0:31increase your muscle repair.
  15. 0:32Really side effect.
  16. 0:33The only one that I would say has a bigger side effect
  17. 0:36would be IGF.
  18. 0:37Now, God forbid if you did have cancer
  19. 0:38circulating within your body,
  20. 0:40or you did have something going on
  21. 0:41and you were taking a high amount of IGF or growth hormone,
  22. 0:44that's when we could see some causes of side effect.
  23. 0:48There are things that your body creates already.
  24. 0:49You're just increasing those
  25. 0:51into helping the recovery,
  26. 0:53whether that's sleep,
  27. 0:55sexual function,
  28. 0:56recovery itself,
  29. 0:58or from a surgery.
  30. 0:59They all help
  31. 1:01no side effects.

@dt.roth's peptide side effects claims, fact-checked

DT Roth

TikTok creator

187.0K viewsWatch on TikTok

Quick answer

The creator argues that peptides like BPC-157 and TB-500 carry no meaningful side effects because they mimic endogenous compounds, while flagging IGF-1 as the primary exception due to cancer risk. This reflects a partial understanding: while these peptides have relatively benign signals in early research, human clinical trial data is sparse, compounded formulations carry unverified purity risks, and supraphysiological dosing of endogenous compounds is not inherently safe. Patients considering peptide therapy should be screened for cancer history, metabolic conditions, and hormone-sensitive disorders before use.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @dt.roth's peptide side effects claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@dt.roth's peptide side effects claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@dt.roth's peptide side effects claims, fact-checked" from DT Roth. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator argues that peptides like BPC-157 and TB-500 carry no meaningful side effects because they mimic endogenous compounds, while flagging IGF-1 as the primary exception due to cancer risk.

The reason this review is not generic is the source wording and the canonical claim label "peptides side effects peptide hrt jointspain athlete bodybuil." In this clip, the useful excerpt is: "So what side effects am I going to get from taking peptides?" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

A 2022 review by Sikiric et al.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator argues that peptides like BPC-157 and TB-500 carry no meaningful side effects because they mimic endogenous compounds, while flagging IGF-1 as the primary exception due to cancer risk.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator argues that peptides like BPC-157 and TB-500 carry no meaningful side effects because they mimic endogenous compounds, while flagging IGF-1 as the primary exception due to cancer risk. This reflects a partial understanding: while these peptides have relatively benign signals in early research, human clinical trial data is sparse, compounded formulations carry unverified purity risks, and supraphysiological dosing of endogenous compounds is not inherently safe. Patients considering peptide therapy should be screened for cancer history, metabolic conditions, and hormone-sensitive disorders before use.
  • No FDA-approved human safety data exists for BPC-157 or TB-500, making absolute safety claims unsupported by current clinical evidence.
  • A 2022 review by Sikiric et al. in Current Pharmaceutical Design found BPC-157 promising in animal models but explicitly noted the absence of large-scale human trials.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • No FDA-approved human safety data exists for BPC-157 or TB-500, making absolute safety claims unsupported by current clinical evidence.
  • A 2022 review by Sikiric et al. in Current Pharmaceutical Design found BPC-157 promising in animal models but explicitly noted the absence of large-scale human trials.
  • IGF-1 at supraphysiological levels is linked to hypoglycemia, colon cancer risk, and acromegaly-like symptoms, not only cancer as the creator suggested (Laron et al., 1992, NEJM).
  • GHRPs like ipamorelin can elevate cortisol and prolactin levels, which are documented pharmacological effects, not side-effect-free responses.
  • Compounded peptides sold for human use have no guaranteed purity or dosing accuracy, introducing a risk category separate from the peptide's inherent biology.
  • The World Anti-Doping Agency bans TB-500 due to its tissue growth effects being insufficiently characterized in humans, contradicting the 'no side effects' framing.
  • The logical claim that 'natural origin equals safety' fails across pharmacology. Insulin, cortisol, and estrogen are all endogenous and all capable of causing serious harm when misused.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @dt.roth actually say?

The creator's core argument is simple: because peptides like BPC-157 and TB-500 are "amino acid profiles" the body already produces, they essentially cannot cause side effects. The only exception they carve out is IGF-1, which they acknowledge could theoretically accelerate existing cancer. Everything else, in their words, has "no really side effect." That's a strong claim, and it deserves scrutiny.

The framing is appealing. If your body already makes something, flooding it with more sounds harmless. But that logic breaks down quickly when you think about cortisol, insulin, or estrogen. All naturally produced. All capable of causing serious harm in excess or in the wrong context.

Does the science back this up?

Not fully. The honest answer is that the safety profile of most research peptides in humans is largely unknown, because most haven't completed rigorous clinical trials. BPC-157, for instance, has promising animal data, but peer-reviewed human safety data is thin. A 2022 review by Sikiric et al. in Current Pharmaceutical Design highlighted BPC-157's potential in gut and tissue repair, but the authors explicitly noted the absence of large-scale human trials.

TB-500 (thymosin beta-4) has similar gaps. There is early human data from wound-healing studies, but the World Anti-Doping Agency bans it for a reason: its systemic effects on tissue growth are not fully characterized. "No side effects" is not the same as "no reported side effects in limited trials." These are very different statements.

IGF-1's risks are better documented. Laron et al. (1992, New England Journal of Medicine) and subsequent literature have linked supraphysiological IGF-1 to colon cancer risk, acromegaly-like symptoms, and hypoglycemia. The creator gets partial credit here for flagging cancer risk, though they significantly understate the other known risks.

What did they get wrong (or right)?

Wrong: The claim that natural origin equals safety is a logical fallacy. Many endogenous compounds become dangerous when administered exogenously at supraphysiological levels. Water-soluble peptides like BPC-157 and ipamorelin can cause nausea, injection site reactions, flushing, and in the case of GHRPs, elevated cortisol and prolactin. These are documented in the limited trials that do exist.

Right: The creator is correct that IGF-1 stands out as the peptide with the most significant risk profile among those discussed. That's accurate. They're also not wrong that BPC-157 and TB-500 have relatively benign signals in animal and early human data compared to something like synthetic GH.

Wrong: Framing BPC-157's effects as purely side-effect-free is misleading. Reported effects in users include dizziness, nausea, and fatigue. More importantly, because BPC-157 is not FDA-approved for human use, compounded versions have no guaranteed purity or dosing accuracy, which introduces its own risk category entirely.

What should you actually know?

The peptide space operates in a regulatory gray zone. Most of these compounds are sold as "research chemicals" and are not FDA-approved for human use. That doesn't make them automatically dangerous, but it does mean the safety data you'd normally rely on to say "no side effects" simply doesn't exist at scale.

Known and plausible side effects across this class include: injection site reactions, water retention (particularly with MK-677 and some GHRPs), increased hunger, elevated prolactin, transient hypoglycemia with IGF-1, and potential unknown long-term effects from chronic use. For anyone with a history of cancer, autoimmune disease, or metabolic disorders, the risk calculus changes meaningfully.

  • BPC-157: Limited human trials. Animal data is promising. Not FDA-approved. Compounded purity is unverified.
  • TB-500: WADA-banned. Systemic tissue growth effects not fully characterized in humans.
  • IGF-1: Real cancer and hypoglycemia risk. The creator's warning here is warranted but incomplete.
  • MK-677: Not technically a peptide. A ghrelin mimetic. Associated with water retention and elevated blood glucose.

The bottom line is that "your body makes it" is not a safety guarantee. Anyone using these compounds should do so under medical supervision and with realistic expectations about what the science currently supports.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

DT Roth · TikTok creator

187.0K views on this video

Side effects??? #peptide #hrt #jointspain #athlete #bodybuilder

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about no fda-approved human safety data exists for bpc-157?

No FDA-approved human safety data exists for BPC-157 or TB-500, making absolute safety claims unsupported by current clinical evidence.

What does the video say about a 2022 review by sikiric et al. in current pharmaceutical?

A 2022 review by Sikiric et al. in Current Pharmaceutical Design found BPC-157 promising in animal models but explicitly noted the absence of large-scale human trials.

What does the video say about igf-1 at supraphysiological levels?

IGF-1 at supraphysiological levels is linked to hypoglycemia, colon cancer risk, and acromegaly-like symptoms, not only cancer as the creator suggested (Laron et al., 1992, NEJM).

What does the video say about ghrps like ipamorelin can elevate cortisol?

GHRPs like ipamorelin can elevate cortisol and prolactin levels, which are documented pharmacological effects, not side-effect-free responses.

What does the video say about compounded peptides sold for human use have no guaranteed purity?

Compounded peptides sold for human use have no guaranteed purity or dosing accuracy, introducing a risk category separate from the peptide's inherent biology.

What does the video say about the world anti-doping agency bans tb-500 due to its tissue?

The World Anti-Doping Agency bans TB-500 due to its tissue growth effects being insufficiently characterized in humans, contradicting the 'no side effects' framing.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by DT Roth, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.